Dr. Paul B. Rothman, dean of the medical faculty and CEO of Johns Hopkins Medicine, and Dr. E. Albert Reece, vice president of medical affairs at the University of Medicine and dean of the School of Medicine, addressed the federal government’s decrease in financial support for biomedical research over the last decade in an article published on Friday, Nov. 7, in The Hill.
“The American research enterprise, long the world’s gold standard for scientific progress, is at risk of slipping behind,” wrote Rothman and Reece in the piece entitled “Poised for big breakthroughs, US scientists find dwindling support.”
Read more on how Rothman and Reese are working to adapt to funding shorfalls, including evaluation of the way they train young scientists, maximizing translational efforts and industry partnerships, and diversifying funding sources.
About Paul B. Rothman, M.D.
Dr. Rothman is the Dean of the Medical Faculty and CEO of Johns Hopkins Medicine. View his profile.
About Johns Hopkins Medicine
JHM unites the physicians and scientists of the School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System. Learn more.